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Cardiac tissue undergoes renewal with low rates.
Although resident stem cell populations have been
identified to support cardiomyocyte turnover, the
source of the cardiac stem cells and their niche
remain elusive. Using Cre/Lox-based cell lineage
tracing strategies, we discovered that labeling of
endothelial cells in the adult heart yields progeny
that have cardiac stem cell characteristics and ex-
press Gata4 and Sca1. Endothelial-derived cardiac
progenitor cells were localized in the arterial coro-
nary walls with quiescent and proliferative cells in
the media and adventitia layers, respectively. Within
the myocardium, we identified labeled cardiomyo-
cytes organized in clusters of single-cell origin.
Pulse-chase experiments showed that generation
of individual clusters was rapid but confined to spe-
cific regions of the heart, primarily in the right anterior
and left posterior ventricular walls and the junctions
between the two ventricles. Our data demonstrate
that endothelial cells are an intrinsic component of
the cardiac renewal process.
INTRODUCTION
Classically, the heart has been thought of as a postmitotic organ
without intrinsic mechanisms to replace cardiomyocytes (CMs).
However, recent studies documented moderate annual CM
renewal rates, averaging 0.4%–1% (Bergmann et al., 2009;
Murry and Lee, 2009). The origins of cardiac tissue renewal
mechanisms have been actively pursued, leading to the identifi-
cation of several distinct cardiac cell types with stem cell charac-
teristics that have been proposed to contribute to maintenance
of the adult mammalian heart (Boudoulas and Hatzopoulos,
2009). One such population consists of cells that form cardio-
spheres in suspension and differentiate to CMs, endothelial cells
(ECs), and smooth muscle cells (SMCs) (Messina et al., 2004;
Smith et al., 2007). Cardiac stem cells (CSCs) also include
c-Kit expressing cells, which generate CMs, ECs, and SMCsafter injury (Beltrami et al., 2003; Rota et al., 2008; Ellison
et al., 2013). A different CSC type consists of Side Population
(SP) cells (Hierlihy et al., 2002; Martin et al., 2004; Mouquet
et al., 2005). The potential of SP cells to differentiate to cardiac
cells is higher in the subgroup that expresses stem cell antigen
1 (Sca1) (Pfister et al., 2005). Sca1+ cells independently isolated
from adult cardiac tissue express early regulators of cardiac dif-
ferentiation suchasGata4and,when stimulated,Nkx2.5 and sar-
comeric proteins (Oh et al., 2003). Sca1+ cells home to infarcted
myocardium, yielding CMs around the injury area and improving
cardiac function (Oh et al., 2003; Wang et al., 2006). Recent tran-
scriptional profiling suggested that c-Kit+ cells represent a less
differentiated phenotype, whereas SP and Sca1+ cells are more
committed to the cardiac lineage (Dey et al., 2013).
Adult organs, including the brain, gut, bone marrow, and hair
follicles, harbor stem cells in specialized niches, allowing for
spatial and temporal regulation of the renewal process (Li and
Clevers, 2010; Fuentealba et al., 2012). The niche supports
quiescent stem cells that upon stimulation give rise to transient
amplifying progenitors that differentiate to mature, tissue-spe-
cific cell types. However, little is known about the origins of
CSCs or the structural organization of the CSC niche in the heart.
We recently showed that after acute ischemic injury in the
adult heart, endothelial-to-mesenchymal transition (EndMT) pro-
duces bipotent cells that generate both ECs and myofibroblasts
during scar formation (Aisagbonhi et al., 2011). Other groups
have documented the ability of adult ECs to generatemultipotent
stem-like cells via EndMT in the bone, demonstrating a degree
of EC plasticity and ability to differentiate to alternative cell
types (Medici et al., 2010). Based on these findings, we hypoth-
esized that ECs may also contribute to the maintenance of car-
diac tissue during homeostasis. Using constitutive and inducible
fate-mapping strategies to track cells expressing endothelial
genes in the adult mouse heart, we discovered that ECs generate
cells with CSC characteristics. EC-derived cells were organized
in a radial manner within coronary arteries, with quiescent and
proliferative cells residing in the media and adventitia layers,
respectively. Distal to the coronary niche, we identified labeled
CMs organized in clusters of single-cell origin. EC pulse-chase
experiments demonstrated that CM renewal was rapid but
spatially restricted. Our data reveal that cells with EC properties
are part of the intrinsic cardiac renewal program and thatCell Reports 8, 229–241, July 10, 2014 ª2014 The Authors 229
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coronary arteries constitute a structural component of the car-
diac stem cell niche.
RESULTS
Endothelial Fate Mapping Labels CMs in the Adult Heart
To investigate the potential role of the endothelium in mainte-
nance of the normal, uninjured adult heart, we analyzed cell fate
in the hearts of 3- to 5-month-old Tie1-Cre-LacZ or Tie1-Cre-
YFP mice, which were generated by crossing Tie1-Cre mice to
ROSA-b-galactosidase (LacZ) or ROSA-enhanced yellow fluo-
rescence protein (YFP) reporter mice, respectively (Gustafsson
et al., 2001; Soriano, 1999; Srinivas et al., 2001) (Figure 1A). In
double-transgenic animals, the ubiquitous Rosa26 promoter
constitutively drives reporter gene expression in ECs and their
progeny.
Tie1-Cre-LacZ hearts were stained with X-gal to visualize
b-galactosidase (b-gal) activity and thus Tie1+ cells and their
derivatives. In addition to labeled ECs as expected, we observed
X-gal+ cells of nonendothelial appearance that were organized in
clusters (Figure 1B). Histological analysis showed that the b-gal+
clusters were CMs, based onmorphology and costaining for car-
diac Troponin T (Figure 1C). To exclude that CMstainingwas due
to aberrant b-gal activity in CMs, we stained cardiac tissue sec-
tions from Tie1-Cre-YFP mice with antibodies that recognize
YFP and the CM marker a-Actinin. Immunofluorescence (IF)
analysis showed robust EC staining, but also revealed the pres-
ence of YFP+ CMswith proper sarcomeric structures (Figure 1D).
EC-derived CMs in sections appeared in clusters, in agreement
with the pattern observed in whole-mount images.
To eliminate the possibility that CM staining was due to
ectopic Tie1 promoter activity in cardiac cells, we used mice
expressing b-gal directly under the Tie1 promoter to mark ECs,
but not their progeny (Korhonen et al., 1995). Histological anal-
ysis at 2 days, 2 weeks, 1 month, and 2 months of age detected
exclusive EC labeling, without b-gal+ CMs (Figure S1). These re-
sults indicate that the labeled CMs observed in Tie1-Cre-LacZ
and Tie1-Cre-YFP hearts were progeny of Tie-1+ cells and not
due to ectopic Tie1 expression in CMs.
To further confirm that ECs give rise to CMs, we used an inde-
pendent mouse line with endothelial-specific Cre expressionFigure 1. Lineage Tracing of EC Fate Leads to CM Labeling in the Adu
(A) Schematic drawing of the gene loci used for EC lineage tracing and fate map
(B) Whole-mount X-gal staining of hearts from 3-month-old Tie1-Cre-LacZ mic
represent boxed areas showing a cluster of labeled non-ECs (upper panel) and E
(C) Upper panel: histological analysis of X-gal-stained cardiac tissue sections fro
ECs costain for cardiac Troponin T (cTnT; arrows). Scale bars, 10 mm.
(D) IF analysis of cardiac tissue from Tie1-Cre-YFP mice stained for YFP (green)
(arrows) are shown sectioned longitudinally (left) and transversely (right). DAPI (b
showcase sarcomeric structures in YFP+ CMs. Scale bars, 50 mm (top panels) a
(E) Histological analysis of X-gal-stained cardiac tissue from VE-Cadherin-Cre-La
in the right image. Scale bars, 25 mm (left panels) and 10 mm (right panel).
(F) IF analysis of cardiac tissue from VE-Cadherin-Cre-YFP mice costained for YF
nuclear counterstaining. Scale bars, 10 mm. See also Figure S1.
(G–I) IF analysis of cardiac tissue from Tie1-Cre-YFP mice indicating YFP (yellow
protein N-cadherin (H, red), and gap junction protein Connexin 43 in intercalated d
magnification insets are shown in the right panels. Arrows indicate adjacent YFP+
(G) and 10 mm (H and I) in original images, and 10 mm (G) and 5 mm (H and I) in inunder the control of the vascular endothelial (VE)-cadherin
gene transcription regulatory elements (Alva et al., 2006) (Fig-
ure 1A). The VE-Cadherin promoter-based labeling produced
results comparable to those obtained with the Tie1-Cre-LacZ
or Tie1-Cre-YFP mice. Specifically, histological sections ob-
tained from 3- to 5-month-old VE-Cadherin-Cre crossed
to ROSA-LacZ (VE-Cadherin-Cre-LacZ) or ROSA-YFP (VE-
Cadherin-Cre-YFP) hearts showed labeling of both ECs and
CMs (Figures 1E and 1F).
IF analysis showed that EC-derived, YFP+ CMs were sur-
rounded by normal basal membrane (Collagen IV staining),
properly expressed cell-adhesionmembranemolecules (N-Cad-
herin), and formed gap junctions (Connexin 43) among them-
selves as well as with non-EC-derived CMs, suggesting that
they are functionally integrated with neighboring YFPCMs (Fig-
ures 1G–1I). Taken together, our results show that in adult mice,
fate mapping using endothelial genetic labeling yields cells with
the functional and structural properties of CMs.
Endothelial-Derived Myocytes First Appear 2 Weeks
after Birth
During development, mesodermal progenitor cells, which differ-
entiate to ECs, CMs, and SMCs, also express the endothelial-
specific gene vascular endothelial growth factor receptor 2
(Vegfr2; Kattman et al., 2006). This raised the possibility that
the labeled CM clusters in the adult heart were derived from early
embryonic cells with endothelial characteristics. To distinguish
whether the EC-derived CMs were of embryonic or adult origin,
we used End-SCL-CreERT mice with inducible Cre recombinase
expression under the control of the 50 endothelial-specific
enhancer of the stem cell leukemia (SCL) gene (Go¨thert et al.,
2004). End-SCL-CreERT mice were crossed to the ROSA-LacZ
or ROSA-YFP reporter lines to generate End-SCL-CreERT-
LacZ or End-SCL-CreERT-YFP mice, respectively. These dou-
ble-transgenic mice allow for specific labeling of mature ECs
after tamoxifen induction of Cre-recombinase activity.
End-SCL-CreERT-LacZ and End-SCL-CreERT-YFP adult mice
were continuously fed a diet containing 0.8% tamoxifen to tag
and lineage trace ECs. Whole-mount staining with X-gal and his-
tological analysis of End-SCL-CreERT-LacZ hearts after 6 weeks
of the tamoxifen diet showed EC as well as CM labeling (Figureslt Heart
ping.
e shows EC labeling and clusters of non-ECs in the ventricles. Right panels
Cs (lower panel). Scale bars, 1 mm in original image, 250 mm in insets.
m Tie1-Cre-LacZ mice shows CM staining (arrows). Lower panel: labeled non-
shows ECs and CMs, with the latter costained for a-Actinin (red). YFP+ CMs
lue) was used for nuclear counterstaining. Lower panels depict boxed areas to
nd 10 mm (bottom panels).
cZ mice shows staining of ECs (left panels). A labeled CM cluster is highlighted
P (top and bottom, green) and a-Actinin (bottom; red). DAPI (blue) was used for
) and basal membrane Collagen IV (G; Col IV, red), membrane cell adhesion
iscs (I; Cx43, red). YFP antibody marks both ECs and EC-derived CMs. Higher-
/YFP+ CMs; arrowheads indicate adjacent YFP+/YFP CMs. Scale bars, 30 mm
sets.
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Figure 2. Endothelial-Derived CMs Appear in the Adult Heart
(A and B) Images of X-gal-stained hearts from 5-month-old End-SCL-CreERT-LacZmice that were fed tamoxifen chow for 6 weeks to induce Cre recombinase in
adult ECs and their progeny. Whole-mount staining in (A) shows EC and CM labeling. Scale bar, 1 mm in original image, 250 mm in inset. Histological sections in
(B) depict labeled CMs (arrows) and ECs (representative arrowheads). Scale bars, 20 mm.
(C) Labeling of cardiac ECs and CMs in the End-SCL-CreERT-YFP double-transgenic line after 12 weeks of the tamoxifen diet. Sections stained for YFP (green)
and a-Actinin (red). Right panel: magnification of the boxed area highlights sarcomeric structures in YFP+ CM. Scale bars, 10 mm (left) and 5 mm (right).
(D and E) Whole-mount images (D) and sections (E) of X-gal-stained neonatal hearts from 2-day-old Tie1-Cre-LacZ mice shows EC, but not CM, labeling. Scale
bars, 1 mm in original images, 250 mm in magnified areas.
(F and G) X-gal staining of hearts fromweanling (2-week-old) and young adult (2-month-old) mice shows that EC-derived CM clusters appear at2weeks of age.
Scale bars, 1 mm.
See also Figure S2.2A and 2B), similar to the constitutively active endothelial-spe-
cific Cre models described in Figure 1. Labeling of CMs, which
costained for sarcomeric a-Actinin, was also observed after
12 weeks on tamoxifen (Figure 2C). Of note, we did not detect
CM labeling and found extremely rare EC labeling (<1%) in
control End-SCL-CreERT-LacZmice without tamoxifen adminis-
tration, indicating tight regulation of inducible Cre recombinase
activity. No labeled cells were present in ROSA-STOP-LacZ
mice on tamoxifen (Figure S2).
To test whether the observed CM staining was due to ectopic
activity of the Tie1 or Endothelial-SCL promoter/enhancer ele-
ments in non-ECs, we stained cardiac tissue sections from
Tie1-Cre-YFP and End-SCL-CreERT-YFP mice with antibodies
that recognize Cre protein. IF analysis showed that Cre expres-
sion was restricted to ECs, supporting an endothelial origin of
labeled CMs (Figure S2). We confirmed the endothelial speci-
ficity of Tie1 expression by costaining cardiac sections from
Tie1-Cre-YFP mice for Tie1 and a-Actinin. We did not detect232 Cell Reports 8, 229–241, July 10, 2014 ª2014 The Authorscolabeling of Tie1 in YFP+ or YFP CMs, showing that CMs
do not express Tie1 (Figure S2). Collectively, these results
indicate that the observed labeling was not due to leaky activity
of the inducible Cre fusion protein, expression of b-gal and
YFP without Cre activity, or aberrant Tie1 or Cre expression
in CMs.
To further exclude the possibility that the EC-derived CMs
were marked during development, we isolated and X-gal stained
hearts from neonatal and young Tie1-Cre-LacZ mice. Staining
of hearts from perinatal day 2 (P2), weanling (P14), and young
adult (2-month-old) mice indicated that while the cardiac vascu-
lature was labeled at each time point (Figures 2D–2G), CM clus-
ters first appeared within the postnatal heart by 2 weeks of age
(Figures 2F and 2G).
In brief, we used three independent, constitutive (Tie1 and
VE-Cadherin) or inducible (End-SCL) endothelial-specific pro-
moters and two independent reporters (LacZ and YFP), all of
which showed similar labeling of ECs and CM clusters. Thus,
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Figure 3. Endothelial-Derived CMs Are of Clonal Origin
(A) Schematic drawing of the ROSA-Confetti reporter gene locus.
(B–E) Epifluorescence analysis for RFP, YFP, and nGFP expression in trans-
verse cardiac sections from adult Tie1-Cre-Confetti mice depicts ECs and
CMs expressing RFP, YFP, and nGFP. CM clusters marked in the boxed areas
in (B) are magnified in (C)–(E). Individual CMs in each cluster express the same
fluorescent protein. Scale bars, 100 mm in (B) and 10 mm in (C)–(E).
(F) 3D reconstruction of a representative CMcluster (eachCMexpressing RFP)
and adjacent ECs expressing YFP. Scale bars, 10 mm.
See also Figure S3.our data support the idea that a subset of CMs in the adult mouse
heart are postnatally derived from ECs.
Clusters of Endothelial-Derived CMs Originate from
Single Cells
The clustering of EC-derived CMs suggested they were clonally
related. To test this model, we crossed the Tie1-Cre line to the
ROSA-Confetti multifluorescent reporter to generate Tie1-Cre-
Confetti mice. The Confetti line carries four distinct fluorescent
protein genes (red, yellow, nuclear green, andmembrane-bound
cyan) in the ROSA locus (Snippert et al., 2010). The fluorescent
protein coding sequences are organized in tandem among
alternating LoxP sites in such a way that recombination of the
ROSA-Confetti allele leads to stochastic expression of RFP,YFP, nuclear GFP (nGFP), or membrane CFP (mCFP). The
construct is designed such that random recombination activates
only one of the fluorescent protein genes, allowing stochastic
labeling of each targeted cell and its descendants with a single
color (Figure 3A). As a result, this fate-mapping strategy can
distinguish whether cells in a cluster are clonally related (i.e.,
generated from a single, labeled progenitor cell) or if each cell
in a cluster has been independently derived. In the first case,
the entire cluster should have CMs of one color; if the latter is
true, individual clusters should consist of cells expressing
different colors (Greif et al., 2012).
Epifluorescence examination of cardiac sections from adult
Tie1-Cre-Confetti mice detected ECs expressing RFP, YFP,
and nGFP in equal proportions (Figure S3) (in our hands, expres-
sion of mCFP in cardiac sections was tooweak to reliably detect;
therefore, we focused further analysis on RFP, YFP, and nGFP).
Among labeled CMs, each individual cluster was marked by
expression of the same single fluorescent protein (Figures 3B–
3E). To calculate the probability (p) that each cluster would
randomly consist of CMs expressing the same fluorescent pro-
tein without being derived from a single cell, we recorded the
size and color of CM clusters with three or more cells in sections
of three independent Tie1-Cre-Confetti mousehearts (FigureS3).
The probability that the observed labeling patterns in this
analyzed set of CMs are due to random recombination events
is p < 1036, indicating that labeled CMs in each cluster are
not independently derived, but originate from a single cell.
Using 3D reconstruction images, we documented that in many
instances individual CM clusters were marked by a different
fluorescent color than the neighboring microvasculature, sug-
gesting that the CM labeling was not due to fusion with ECs (Fig-
ure 3F). Furthermore, CMs in the same cluster were not always
contiguous and often were interspersed with unlabeled CMs.
This pattern is also observed in other organs and might be indic-
ative of tissue repair in the adult rather than de novo develop-
ment in the embryo (Kopinke et al., 2011; Bowman et al.,
2013). Collectively, the staining patterns in Tie1-Cre-Confetti
mice indicate that each labeled CM cluster originated from a sin-
gle parental cell expressing EC markers. It is also possible that
rare, proliferating CMs transiently express endothelial markers
and thus become labeled before they expand to form clusters.
Cardiac Myocyte Progeny of ECs Are
Regionally Restricted
Whole-mount heart staining indicated that EC-derived CM clus-
ters were localized in specific areas (Figures 1B, 2F, and 2G). To
determine overall distribution patterns throughout right and left
ventricles, we systematically mapped the location of CM prog-
eny following EC lineage tracing. We analyzed complete sets
of serial transverse cardiac tissue sections from five Tie1-Cre-
YFP mice using confocal microscopy. The results revealed that
clusters of labeled CMs were present in both the left and right
ventricles, most frequently around coronary blood vessels in
subepicardial regions (Figures 4A and 4B). The locations of clus-
ters containing four or more YFP+ CMs were placed in a diagram
of four heart planes from base to apex. We found that YFP+ CM
clusters were primarily localized in three regions of the heart: the
anterior free wall of the right ventricle, the junction areas betweenCell Reports 8, 229–241, July 10, 2014 ª2014 The Authors 233
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Figure 4. Endothelial-Derived CMs Are
Localized to Three Specific Heart Areas
(A) A transverse cardiac section from adult Tie1-
Cre-YFP mice stained for YFP reveals that EC-
derived YFP+ CMs are found in both the left and
right ventricles, most frequently in perivascular
(insets 1–3) and subepicardial (insets 1 and 3)
areas. Scale bars, 500 mm in original image and
10 mm in insets.
(B) Clusters of CMs are also localized at the
junction of the left and right ventricles and adja-
cent septum. Scale bars, 50 mm.
(C) Schematic drawing depicting the location of all
clusters of four or more YFP+ CMs identified in
serial sections of five Tie1-Cre-YFP mice.
(D) Quantification of CM cluster locations shows
that 60% are present in the left ventricle and the
remaining 40% are present in the right ventricle
and junction areas.
(E) Quantification of the number of CMs in each
cluster shows that on average, clusters in the left
ventricle have twice as many CMs as those in the
right ventricle. AA, atrial appendage; RV, right
ventricle; LV, left ventricle; JX, junction; L, lumen.the right and left ventricles and adjacent septum, and the lateral
free posterior wall of the left ventricle (Figure 4C).
Each cluster consisted of up to 50 CMs; 60% of the observed
clusters were in the left ventricle and the remaining 40% were
equally distributed in the right ventricle and junction areas.
Furthermore, on average, the left-ventricle clusters consisted
of twice as many cells per cluster compared with those in the
right ventricle (Figures 4D and 4E). Taking into account the num-
ber of clusters in each heart and the number of cells per cluster,
we calculated that the total number of YFP+ CMs represent
0.3% of the 8 million CMs in the mouse heart (Adler et al.,
1996; Doevendans et al., 1998). These data indicate that in
both ventricles, the cardiogenic endothelium seeds specific car-
diac areas, representing a relatively small fraction of the CM
population.
Pulse Labeling of ECs Leads to Rapid Long-Term
CM Labeling
To test whether ECs are the originating cells or represent an
intermediate, transient step in the cardiogenic process, we
pulse-chased ECs using the inducible End-SCL-CreERT-LacZ
mouse described above. Adult mice were given a series
of closely spaced tamoxifen injections (‘‘pulse’’) and hearts
were isolated at various time points after the final injection
(‘‘chase’’) (Figure 5A). Their hearts were then stained with
X-gal to visualize labeled CMs in transverse sections. Analysis
of cardiac tissue sections immediately (i.e., 1 day after the end
of the pulse) and 3 days later showed exclusive labeling of234 Cell Reports 8, 229–241, July 10, 2014 ª2014 The AuthorsECs, whereas labeled CMs appeared
1 week after the pulse and persisted up
to 12 weeks, the last time point examined
(Figure 5B).
The number of labeled CMs per volume
of cardiac tissue was quantified for eachtime point. The data indicate that labeled CMs appeared in low
numbers 1 week after the pulse, increased over a period of
3 weeks, and remained relatively constant for at least up to
12 weeks (Figure 5C). These results suggest that cells labeled
by EC-specific Cre expression represent an originating cell
rather than a transient subpopulation in the CM generation pro-
cess, since in the latter case CM numbers would decline after a
single pulse. Alternatively, it is likely that EC-derived CMs have
long lifespans beyond the examined 12-week period. In either
case, the duration required to achieve maximum CM labeling
after the pulse suggests the process is rapid and reaches a
steady state within 3 weeks.
SCL, Tie1, and VE-Cadherin are also expressed in hemato-
poietic stem cells (HSCs), raising the possibility that the
labeled CMs are of bone marrow origin. One advantage of
the SCL 50 enhancer is that it is not expressed in adult HSCs
(Go¨thert et al., 2004), which suggests that labeled CMs are
derived from ECs and not bone marrow cells. To directly test
whether HSCs contribute CMs in the adult heart, we used a
method that is independent of lineage tracing. Specifically, we
analyzed cardiac tissues from mice transplanted with fluores-
cently tagged bone marrow cells (Figure S4). IF analysis
showed that bone-marrow-derived cells present in the adult
heart were primarily F4/80+ macrophages and FSP-1+ fibro-
blasts, with no labeling of CMs, consistent with previous studies
(Murry et al., 2004). The results of the transplantation studies
excluded the possibility that the labeled CM clusters were
derived from HSCs.
BCA Figure 5. Pulse-Chase Labeling of ECs
Leads to Rapid Long-Term Labeling of
CM Progeny
(A) Schematic drawing of the pulse-labeling
experimental design.
(B) Histological analysis of hearts stained with
X-gal and counterstained with H&E to visualize
ECs and labeled CMs in transverse sections at the
indicated time points. After 1- and 3-day chases,
labeling of only cardiac ECs was observed,
whereas labeled CMs appeared by 1 week after
the pulse and persisted at 3 months. Arrows indi-
cate X-gal+ CMs. Scale bars, 50 mm (upper) and
20 mm (lower panels).
(C) Quantification of CM numbers at different
chase time points shows maximum CM labeling
within 3 weeks, which remains constant thereafter
(n, number of mice used for analysis). Values re-
ported as mean ± SD; *p < 0.05, **p < 0.01.
See also Figure S4.Endothelial Fate Mapping Identifies Quiescent and
Proliferating Perivascular Cells Expressing Early
Cardiac Markers
The above results indicate that ECs represent an originating
source of CMs rather than a transient cell type. This model pre-
dicts that EC lineage tracing will mark intermediate, proliferating
cell populations that express early cardiac markers but have
not yet differentiated to CMs.
In support of this model, an examination of cardiac tissue
sections obtained from Tie-Cre-YFP, Tie-Cre-LacZ, and End-
SCL-CreERT-LacZ mice revealed that besides ECs and CMs,
EC fate mapping marked two additional cell types (Figures 6A,
6B, and S5A–S5C). The first resided in the media layer of coro-
nary arteries and was marked by expression of a smooth muscle
actin (aSMA) (Figure 6A). YFP+/aSMA+ double-positive cells
in the media layer of coronary vessels, termed M cells, also
expressed the early cardiac transcription factor Gata4, but lost
expression of the EC marker CD31 (arrow, Figure 6B). Serial
histological analysis revealed that half of the coronary artery sec-
tions had M cells, which constituted approximately 27% of
the SMC population in those coronary arteries. Moreover, 44%
of the YFP+/aSMA+ M cells expressed nuclear Gata4 protein
(Figure 6C).
The second subpopulation, termed A cells, was found within
or immediately adjacent to the adventitia layer of coronary
vessels (Figures 6B and 6E–6G). Approximately half of the
coronary arteries had A cells, and nearly 65% of them expressed
Gata4 (Figures 6B, 6D, and S5A). The A cells did not express
EC markers, as indicated by the absence of CD31 expression,
and were also negative for mature CM markers such as
a-Actinin (Figures 6E and 6F). The A cells were often small in
size and found in clusters that stained with antibodies recog-Cell Reports 8, 229–nizing the cell-cycle markers Ki67
and phospho-Histone H3 (pH3) (Figures
6F and 6G). Approximately 20% of A
cells stained positive for proliferation
markers (Figure 6H). The proliferative
phenotype was a unique property of Acells among all labeled cell types identified in the cell-fate-
mapping experiments.
Furthermore, lineage tracing using Tie1-Cre-Confetti mice
indicated that coronary ECs and M cells were heterogeneously
labeled and expressed different-colored fluorescent proteins
(Figures 6I and 6J). In contrast, A cell clusters were uniformly
marked by the same color of fluorescent protein, suggesting
that A cell clusters expand from a single cell, consistent with their
expression of proliferation markers (Figures 6J and S5D). Pulse-
chase analysis of ECs using the inducible End-SCL-CreERT-
LacZ mouse showed that EC-derived perivascular M and A cells
could be detected as early as 3 days after the end of the tamox-
ifen pulse (Figure S5C).
IF analysis showed no Cre recombinase protein expression
in labeled M and A cells, supporting an endothelial origin (Fig-
ure S5E). Consistent with this possibility, staining of heart tissue
sections from Tie1-Cre-YFP and wild-type C57Bl/6 mice with
antibodies recognizing mesenchymal markers illustrated that
a rare subpopulation of coronary endothelium, representing
2.5% of coronary ECs, expresses the mesenchymal marker
FSP-1 (Zeisberg et al., 2007) as well as proteins that are known
to initiate mesenchymal transformation, such as Snail (Timmer-
man et al., 2004) (Figures 6K, 6L, S5F, andS5G). Subcellular Snail
localization was observed in both nuclear and cytoplasmic com-
partments, a pattern that depends on the activation state of Snail
(Domı´nguez et al., 2003). These data lend support to the idea that
labeled perivascular cells of EC origin are derived by EndMT.
Endothelial Progeny in Perivascular Areas include
Sca-1+ Cardiac Progenitor Cells
The results of the lineage tracing experiments and the identifica-
tion of EC-derived intermediate cell populations suggested that241, July 10, 2014 ª2014 The Authors 235
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Figure 7. Endothelial Fate Mapping Yields
Cardiac Progenitor Cells
(A and B) IF analysis of cardiac tissue sections
from Tie1-Cre-YFP mice reveals that YFP+/CD31
A cells express Sca1 (A), whereas a small
subpopulation expresses c-Kit (B). Arrows in
magnified areas in (A) indicate YFP+/Sca1+ cells,
and arrowheads indicate Sca1+ ECs. Arrows in
(B) indicate cKit+ cells in magnified areas. DAPI
was used for nuclear counterstaining. Scale
bars, 5 mm.
(C) Serial section analysis of cardiac tissue shows
that 40% and 5% of A cells are Sca1+ or c-Kit+,
respectively.
(D) 3D reconstruction illustrates endothelial-
derived M and A cells (highlighted in white;
representative cells are marked by M and A,
respectively) within the coronary niche. EC in-
dicates coronary ECs. Scale bar, 30 mm.
(E) Schematic drawing of the cardiac stem cell
niche model illustrates the spatial organization of
EC progeny and their corresponding expression
profiles.
See also Figure S6.these intermediates represent cardiac progenitor cells. To test
this possibility, we stained cardiac tissue sections from Tie1-
Cre-YFP mice with antibodies recognizing Sca1 and c-Kit, two
established cell-surface markers of CSCs. The results showed
that M cells did not express either marker. However, 42% of
the YFP+ A cells stained positive for Sca1, whereas only a small
subset (5%) of A cells stained positive for c-Kit (Figures 7A–7C).
Further histological analysis showed that the majority (>70%) of
perivascular, Sca1+/CD31 cells expressed YFP. These results
suggest that a significant fraction of Sca1+ CSCs are descen-
dants of ECs. 3D reconstruction of a coronary artery, using
z-stack imaging, provided a physical depiction of the spatialFigure 6. Endothelial Fate Mapping Yields Two Distinct Types of Periv
(A–G) IF analysis of cardiac tissue sections from Tie1-Cre-YFP mice.
(A) YFP+/aSMA+ cells (termedMcells) are present in themedia layer of coronary ar
these and subsequent IF images.
(B) YFP+/CD31 cells (termed A cells) are present within or immediately adjacent
both M (arrows) and A (arrowheads) cells acquire expression of Gata4 protein (s
(C) Quantification using cardiac tissue serial sections reveals that 52.6% of the
27% of SMCs are EC-derived M cells (middle) and 44% of the M cells express
(D) Quantification using serial sections reveals that approximately half of the coro
cells express Gata4 (right).
(E) A cells are often found in close proximity to YFP+ CMs (arrows). YFP+ A cel
bars, 10 mm.
(F) A cells (arrowheads in magnified boxed area) do not express a-Actinin, but s
(G) A cells (arrows in magnified boxed area) stain positive for the proliferation ma
(H) Ki-67+ (top graph) and pH3+ (bottom) cells represent 20% and 16% of A ce
(I and J) Epifluorescence analysis of cardiac sections from Tie1-Cre-Confetti mic
(I) Images show heterogeneous labeling of M cells expressing either RFP or YFP (
and 20 mm for inset.
(J) Clusters of A cells are uniformly marked by a single color of fluorescent prote
labeling of fluorescent M cells (with RFP, YFP, or nGFP) is seen in the media lay
(K) IF analysis of cardiac sections from C57Bl/6 mice stained for CD31 (red), aSM
(L) Cardiac sections from Tie1-Cre-YFP mice show that a subpopulation of corona
cytoplasmic costaining. Scale bars, 10 mm for originals and 5 mm for insets. L, M, a
the coronary arterial wall.
See also Figure S5.arrangement of M and A cells within the coronary niche (Figures
7D and S6).
Considering the results described above and taking into ac-
count the cellular spatial relationships (i.e., the distance from
the coronary endothelium), we propose the following model (Fig-
ure 7E): endothelial or endothelial-like cells give rise to quies-
cent, perivascular cells in the coronary wall that lose ECmarkers
and acquire SMC characteristics. These cells, termed M cells,
express early cardiac differentiation markers such as Gata4.
Further distal to the vascular wall, M cells are replaced by A cells,
which lose SMC characteristics but maintain expression of
Gata4, and acquire markers of CSCs such as Sca1+. The A cellsascular Cells
teries (arrows). Scale bars, 10 mm.DAPI was used for nuclear counterstaining in
to the adventitia layer of coronary vessels. The magnification inset shows that
ee also Figure S5A). Scale bars, 10 mm.
coronary arteries contain EC-derived M cells (left graph). In these coronaries,
Gata4 (right).
nary arteries contain endothelial-derived A cells (left graph) and 65% of the A
ls lost CD31 expression (arrowheads in magnified boxed areas below). Scale
tain positive for the proliferation marker Ki-67.
rker pH3. Arrowheads indicate YFP+ ECs. Scale bars, 5 mm.
lls, respectively.
e.
arrows). Arrowheads indicate RFP+ or YFP+ ECs. Scale bars, 50 mm for original
in (YFP). In the magnified area, arrows point to YFP+ A cells. Heterogeneous
er (arrowheads, merge). Scale bars, 20 mm for original and 5 mm for insets.
A (green), and FSP-1 (white) indicates a rare population of CD31+/FSP1+ ECs.
ry ECs express Snail. Arrowheads indicate nuclear costaining; arrows indicate
nd A in (I) and (J) insets stand for lumen, media, and adventitia, respectively, of
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proliferate, leave the coronary niche, and differentiate to CMs.
Thus, EC-derived YFP+ M and A perivascular cells within the
medial and adventitial layers of coronary vessels likely serve as
intermediate populations during generation of adult CMs.
Although the proposed model is consistent with the observed
data, alternative interpretations may also explain the pattern of
the lineage tracing results. For example, low-level expression
of endothelial genes in cardiac fibroblasts with cardiogenic po-
tential could account for some of the observed labeling patterns.
Or, as mentioned above, rare proliferating CMs may transiently
express endothelial genes and thus become labeled before
expansion occurs. Although we did not observe expression of
endothelial markers in fibroblasts and CMs, we cannot fully
exclude these possibilities.
DISCUSSION
Current evidence showing low rates of CM apoptosis suggests
that a renewal mechanism is required to maintain cardiac tissue
(Anversa et al., 2006; Ellison et al., 2007), yet there is little infor-
mation regarding the native regenerative mechanisms that
function during cardiac homeostasis. We used Cre/Lox technol-
ogy to generate a fate map of vascular cells in the healthy,
adult heart. Our data show that (1) ECs retain cardiogenic poten-
tial in the adult heart, similar to the differentiation capacity of car-
diovascular progenitor cells during the early stages of cardiac
development; (2) the EC-based cardiogenic process is rapid
but restricted to specific areas of the myocardium; (3) 0.3%
of the adult heart is comprised of endothelial-derived CMs;
(4) the EC-based regenerative mechanism generates both
quiescent (M cells) and proliferative (A cells) progeny expressing
early-stage cardiac differentiation genes such as Gata4; (5)
Sca1+ cardiac stem cells are EC progeny; and (6) the coronary
arteries serve as a structural component of the cardiac stem
cell niche.
Although the classical role of ECs is to ensure proper func-
tioning of the inner wall in blood vessels, increasing evidence in-
dicates that they have exceptional differentiation potential and
plasticity, and thus play amore direct role in organ development,
homeostasis, and repair. During development, for example,
hemogenic endothelia in the ventral wall of the dorsal aorta
transform into budding blood cells and migrate to hematopoietic
organs, ultimately residing in the bone marrow (Lancrin et al.,
2009). In the adult, besides the angiogenic response of ECs to
build new blood vessels after ischemia, they also undergo
EndMT after injury, producing SMA+ myofibroblasts in the heart,
lung, and kidney, supporting a fibrogenic potential of ECs (Zeis-
berg et al., 2007, 2008; Arciniegas et al., 2007; Aisagbonhi et al.,
2011; Chen et al., 2012).
Our results indicate that ECs also have cardiogenic potential in
the adult. This notion is compatible with embryonic development
when all three types of cardiovascular cells (ECs, SMCs, and
CMs) are derived from multipotent progenitor cells expressing
EC markers such as Vegfr2 (Kattman et al., 2006). Furthermore,
inactivation of SCL/TAL1 can transform vasculature to cardiac
cells, turning the yolk sac from a hematopoietic tissue to a con-
tracting sheet of CMs (Van Handel et al., 2012). This striking
outcome suggests that, at least early in development, the EC-238 Cell Reports 8, 229–241, July 10, 2014 ª2014 The Authorsto-CM transition can be accomplished by switching off a single
transcriptional regulator.
Collectively, the data obtained here during cardiac homeosta-
sis and previous data showing that ECs contribute to angiogen-
esis and fibrosis after injury indicate that ECs remain multipotent
in the adult. However, it is not clear whether this is a universal
property of mature cardiac ECs or is confined to specific EC sub-
populations within coronary arteries. It is also likely that a multi-
potent cardiovascular stem cell expressing EC markers exists in
the adult and is genetically labeled by EC lineage tracing ap-
proaches. Finally, the cardiogenic endothelium may represent
one mechanism of cardiac regeneration, but our findings do
not exclude the possibility of alternative sources of CSCs or
the proliferation of resident CMs (Senyo et al., 2013; Malliaras
et al., 2013).
Our data provide evidence that the majority (>70%) of Sca1+
CSCs are derived from cells with endothelial characteristics.
EC-derived Sca1+ cells expressed early cardiac markers such
as Gata4, but lacked mature CM characteristics such as sarco-
meric structures and a-Actinin expression. Interestingly, lineage
tracing of Sca1+ CSCs showed that they give rise to myocardial
cells in the adult heart (Uchida et al., 2013). We found limited
overlap between endothelial-derived YFP+ cells and c-Kit+ cells,
by contrast, suggesting that the majority of c-Kit+ cells in the
heart belong to a different lineage.
An important result of EC lineage tracing during cardiac ho-
meostasis is the emergence of the coronary arteries as the site
of the CSC niche. Previous studies showed that the vasculature
is an integral component of most well characterized stem cell
niches in various organs, such as the bone marrow and the sub-
ventricular zone (SVZ) in the brain (Li and Clevers, 2010; Fioret
and Hatzopoulos, 2014). Our data suggest that this biological
strategy extends to the heart, with the coronary vessels serving
as the CSC niche. In support of this finding, vascular progenitor
cells have been observed in the walls of coronary arteries in the
human heart (Bearzi et al., 2009).
Moreover, our data show that EC-derived Gata4+ cells around
the coronary arteries can be divided into subpopulations based
on several criteria (location, size, molecular markers, and prolif-
eration status), indicating the CSC niche is organized in a radial
manner with the vasculature at the center. M cells, which are
closest to the lumenal ECs, are quiescent and combine smooth
muscle and early cardiac characteristics, whereas A cells farther
afield in the adventitia are proliferative and acquire expression of
Sca1. In many respects, the CSC niche shares similarities with
the neuronal stem cell niches in the brain. Here, neuronal stem
cells in the SVZ give rise to astrocytes (a mesenchymal cell pop-
ulation similar to aSMA+ cells), which differentiate to groups of
proliferating cells before joining the rostral migratory stream
(Fuentealba et al., 2012). The cardiac renewal process is also
confined to a small subpopulation of mature CMs, similar to
what is observed in the adult brain, where renewal is mainly
restricted to the olfactory bulb and dentate gyrus.
Our data indicate that ECs, through the process of EndMT, are
capable of generating cells with CSC characteristics in the unin-
jured adult heart. Other investigators and we have shown that
TGF-b/BMP and Wnt signaling pathways regulate EndMT after
injury, and it is likely that these pathways also regulate the
process during homeostasis (Zeisberg et al., 2007; Aisagbonhi
et al., 2011; Chen et al., 2012). In addition, Sonic hedgehog
signaling has been shown to activate Sca1+ cells that have
stem cell properties and reside in the adventitia layer of the arte-
rial wall, and may also influence cardiogenic EC fate (Passman
et al., 2008). The mechanisms that direct trafficking of the endo-
thelial-derived cardiac progenitors remain to be determined. It is
possible that A cells enter the circulation and are recruited to
distal heart areas by chemokines such as SDF-1, similarly to
mesenchymal stem cells (Wynn et al., 2004; Laird et al., 2008).
Alternatively, local gradients of chemoattractants may recruit
cells from their niche.
It is intriguing that adult ECs can give rise to myofibroblasts
after cardiac injury (Zeisberg et al., 2007; Aisagbonhi et al.,
2011). The striking parallels regarding the origins of CSCs and
myofibroblasts raise the possibility the two processes are intrin-
sically linked. Thus, EC-derived CSCsmay switch to a profibrotic
phenotype in the disease environment after injury and alter their
differentiation from CMs to myofibroblasts to preserve ventricu-
lar integrity. This scenario is reminiscent of the situation in skel-
etal muscle, where myoblasts switch from a regenerative to a
profibrotic phenotype with aging (Brack et al., 2007). The ability
of endogenous cardiac cells to change their fate based on their
environment is further supported by a recent exciting finding that
after cardiac injury, murine cardiac fibroblasts can be reprog-
rammed in vivo into CMs (Qian et al., 2012).
Our results also show that EC-derived CMs represent a small
fraction of the total cardiac cell pool and are confined to specific
areas. The first observation probably reflects the slow rate of car-
diac renewal that is necessary during cardiac homeostasis, as
evidenced by the low number of new CMs that are generated
annually in human and mouse hearts (Bergmann et al., 2009;
Murry and Lee, 2009). The second observation suggests that
renewal may take place in specific sites characterized by high
attrition rates due to work overload or structural constrains. In
support of this possibility, clinical studies showed that cardiac
tissue fibrosis often appears in the perivascular space or the
insertion points between ventricles (Biernacka and Frangogian-
nis, 2011; Karamitsos and Neubauer, 2013), sites that contain
many of the labeled clusters we identified in the mouse hearts.
Our model may also provide novel insights into how coronary
arterial disease can lead to heart failure. It is likely that inflamma-
tion, oxidative stress, ischemia, calcification, and fibrosis around
coronary vessels negatively impact the niche environment, dis-
turbing the normal proliferation and differentiation of CSCs.
This effect could compromise cardiac homeostasis, weaken
the heart muscle, and eventually lead to hypertrophy and remod-
eling. Therefore, our findings may present novel opportunities to
establish intrinsic cardiac molecular mechanisms and identify
factors that prevent a profibrotic fate switch after injury in favor
of cardiac regeneration.EXPERIMENTAL PROCEDURES
Animals
ECs and their progeny were genetically labeled using Cre-LoxP recombination
tools to activate expression of b-gal or various fluorescent proteins under the
control of the ubiquitously active ROSA gene locus (Soriano, 1999). Threeindependent transgenic mouse lines were used to direct constitutive or
inducible Cre recombinase activity specifically in ECs: the Tie1-Cre and
VE-Cadherin-Cre lines (Gustafsson et al. 2001; Alva et al., 2006) and the endo-
thelial-SCL-Cre-ERT line, which drives a tamoxifen-inducible Cre-ERT recom-
binase under control of the 50 endothelial-specific enhancer of the SCL gene
locus (Go¨thert et al., 2004). The EC-specific Cre lines were crossed to
R26RstopLacZ (Soriano, 1999) or R26RstopYFP (Srinivas et al., 2001) mice
to generate double transgenics. The Tie1-Cre mouse line was also bred with
the multifluorescent reporter R26RstopConfetti (Snippert et al., 2010). Finally,
transgenic mice expressing b-gal directly under the Tie1 promoter (Korhonen
et al., 1995) were used to assess Tie1 expression in cardiac tissue. All animal
experiments were approved by the Vanderbilt University Institutional Animal
Care and Use Committee.
Whole-Mount b-Gal Activity Staining Assay
Whole mouse hearts were isolated into cold 13 PBS and fixed for 1 hr at 4C
in 13 PBS containing 2% paraformaldehyde (PFA). After fixation, the hearts
were washed thrice with 13 PBS for 15 min each and kept overnight
(O/N) at 30C in X-gal staining solution (1 mg/ml X-gal, 5 mM potassium ferro-
and ferricyanate, 2 mM magnesium chloride, and 0.02% NP-40 in 13 PBS).
Whole-mount hearts were photographed, stored in 10% phosphate-buffered
formalin at room temperature (RT) O/N and embedded in paraffin for
sectioning.
Immuno- and Epifluorescence
For cryosectioning, freshly isolated hearts were perfused with 13 PBS, bi-
sected transversely, and fixed in 4% PFA dissolved in 13 PBS for 2 hr at
RT. The hearts were rinsed thrice in 0.1% TX-100 solution in 13 PBS for
5 min each, embedded in Optimal Cutting Temperature compound (OCT;
VWR), sectioned, and stored at 70C. Slides were thawed at RT and rehy-
drated in 13 PBS for 30 min to remove the OCT. Sections were washed twice
in 0.1% TX-100 solution for 3 min each and permeabilized in 0.5% TX-100
solution for 20 min at RT. The sections were then blocked in 0.1% TX-100
solution containing 2% BSA and 10% normal goat serum (Sigma) for 30 min
at RT, and incubated with primary antibodies O/N at 4C. Afterward, the slides
were washed four times in 13 PBS for 10 min each, incubated with secondary
antibodies in blocking solution for 1 hr at RT, washed four times in 13 PBS for
10 min each, and mounted with VECTASHIELD fluorescent mounting medium
(Vector Laboratories). Antibody sources and dilutions are described in Supple-
mental Experimental Procedures.
Imaging and 3D Reconstruction
A series of confocal images (z stack) were acquired sequentially on 100 mm
cardiac sections. Image stacks were attained for each channel using an
LSM 710 META inverted microscope (Zeiss). Images were maximally pro-
jected using ZEN or ImageJ software and reconstructed into 3D Z series using
Imaris (Bitplane) image analysis software.
Quantification of Endothelial-Derived CMs per Volume of Cardiac
Tissue in Pulse-Chase Experiments
Cardiac cross-sections from End-SCL-CreERT-LacZ mice were stained with
X-gal for b-gal activity and counterstained with hematoxylin and eosin (H&E),
and then analyzed to determine the number of labeled CMs per volume of
cardiac tissue. Transverse cardiac sections were imaged (Nikon AZ-100M
widefield) and the average area was calculated using the Region Measure-
ments function of MetaMorph image analysis software. The mm/pixel calibra-
tion value was used to convert pixels into area of tissue in mm2. The volume of
total cardiac tissue in mm3 was calculated by multiplying the area obtained per
section by the 10 mm thickness of tissue for each slide. A total of 352 slides
(with four separate sections per slide, for a total of 1,408 sections) were imaged
to analyze and estimate global cardiac CM labeling in the End-SCL-CreERT-
LacZ pulse-chase lineage tracing experiments (n = 17 mice).
Statistical Analysis
All values were reported as mean ± SD. Statistical significance was assessed
by Student’s unpaired two-tailed t test for all statistical analysis comparisons.
Statistical significance was expressed as follows: *p < 0.05, **p < 0.01.Cell Reports 8, 229–241, July 10, 2014 ª2014 The Authors 239
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